CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MORPHEUS project aims to optimize anticoagulant treatment duration for patients with unprovoked venous thromboembolism by integrating clinical and socio-anthropological data. It seeks to develop personalized prediction tools to improve patient outcomes and reduce unnecessary bleeding risks.
Venous thromboembolism (VTE) is a frequent and life-threatening disease.
In 50% of cases, VTE occurs in the absence of any major risk factors (unprovoked VTE).
In these patients, when anticoagulation is stopped after 3 months of anticoagulation, more than 35% will develop recurrent VTE.
Consequently, international guidelines recommend to treat these patients “indefinitely”.
However, such practice exposes them to a substantial increase risk of bleeding.
Nevertheless, after several years of antico…
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, BREST
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, PARIS
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
